Key contributors include urbanization, an ageing population, decreasing levels of physical activity, and increasing prevalence of overweight and obesity
Originally developed to treat type 2 diabetes, it has shown promise in helping individuals lose weight
doi:10.2337/dc24-S004 Watanabe JH, Kwon J, Nan B, Reikes A
Which companies hold the strongest visible positions in current GLP-1 meal replacement workflows
Complete drug delivery systems can be developed by encapsulating drugs with SPIONs and modifying their surfaces with surfactant materials, enabling targeted and precise drug therapy [86]
Need access to multiple GLP-1 medication options including brand-name drugs